Founded in Cleveland in 2018 by medical-device entrepreneurs and Case Western Reserve University researchers, CollaMedix develops collagen-based medical devices using its patented electrocompaction technology. Its signature CollaFabric® is a load-bearing pure collagen fabric made from dense, aligned threads, with applications under development in tendon repair and female pelvic health. The company has received $8 million in grant funding from the National Science Foundation, National Institutes of Health, and other public entities.
Financial Conflicts of Interest Policy compliant with 42 CFR 50, Subpart F
compliance_program